Research carried out as a result of the toxicity of aspirin on cats has led to an improved knowledge of the metabolism of this species. Laboratories have consequently had access to the necessary fundamental data to develop adapted specialities. The increasing use of medication on cats has led to the commercialisation of three different families of injectable or oral NSAIs, in spite of the practical difficulties of experimentation on this specis.